Longenesis

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Longenesis - overview

Established

2017

Location

Riga, -, Latvia

Primary Industry

Biotechnology

About

Longenesis is a healthcare technology company focused on optimizing data management solutions, enhancing operational efficiencies, and improving patient outcomes through innovative tools and services. Founded in 2017 and headquartered in Riga, Latvia, Longenesis specializes in healthcare data management. The company raised EUR 1 million in Seed funding on June 30, 2021, which will support its strategic initiatives. Garri Zmudze is the founder, while Emil Syundyukov serves as CEO.


Longenesis offers a comprehensive suite of products designed to enhance operational efficiency within the healthcare sector. Their key tool, Engage Curator, streamlines clinical data management for hospitals and researchers, addressing challenges such as data fragmentation. The company serves various markets, including North America and Europe, providing tailored solutions to hospitals, academic institutions, and research organizations. In 2023, Longenesis reported revenue of EUR 404,658.


70, with an EBITDA of EUR -259,229. 20, reflecting its focus on developing robust solutions for healthcare data management. With the EUR 1 million raised in Seed funding, Longenesis plans to expand its presence in key markets and scale the deployment of its three core products: Longenesis Curator, Longenesis Themis, and Longenesis Engage. The company is targeting market expansions within North America and Europe, aiming to enhance its service delivery and operational capacity.


Primary Industry

Biotechnology

Sub Industries

Biotechnology, Medical Devices & Equipment

Website

www.longenesis.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.